Page last updated: 2024-10-15

phenylbutazone, propyphenazone drug combination

Description

phenylbutazone, propyphenazone drug combination: RN given refers to combination of aminopyrine and phenylbutazone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130476758
MeSH IDM0308416

Synonyms (9)

Synonym
rheopyrine
reopirin
rheumopyrine
3,5-pyrazolidinedione, 4-butyl-1,2-diphenyl-, ion(1-), sodium, mixt. with 4-(dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one
phenylbutazone - propyphenazone
8066-94-2
wofapyrin, phenylbutazone, sodium salt
phenylbutazone, propyphenazone drug combination
reopin g

Dosage Studied

ExcerptReference
" On the other hand despite a relatively highly dosed one-week treatment propyphenazone did not lead to changes of the demethylation capacity of the liver in the majority of the patients."( [Effect of propyphenazone on drug biotransformation in the liver. A comparison with phenylbutazone using the aminopyrine breath test].
Clemens, M; Reinicke, C; Steiner, A; Stiller, KJ; Tanner, E; Wächter, G, 1988
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (137)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990134 (97.81)18.7374
1990's1 (0.73)18.2507
2000's1 (0.73)29.6817
2010's1 (0.73)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.43%)5.53%
Reviews0 (0.00%)6.00%
Case Studies5 (3.57%)4.05%
Observational0 (0.00%)0.25%
Other133 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]